Optimal age to stop surveillance in the older population at risk for gastric cancer

Endoscopy 2025; 57(S 02): S109
DOI: 10.1055/s-0045-1805308

Abstracts | ESGE Days 2025

Oral presentation

Screening and Surveillance of Gastric Neoplasia 04/04/2025, 14:00 – 15:00 Room 122+123

JK F Pluimers

¹Erasmus University Medical Center, Rotterdam, Netherlands

,

N Kapteyn

¹Erasmus University Medical Center, Rotterdam, Netherlands

,

I L Holster

²Maasstad Hospital, Rotterdam, Netherlands

,

L G Capelle

³Meander Medical Center, Amersfoort, Netherlands

,

R Verhoeven

⁴Netherlands Comprehensive Cancer Organization, Rotterdam, Netherlands

,

I Lansdorp-Vogelaar

¹Erasmus University Medical Center, Rotterdam, Netherlands

,

J Honing

⁵Erasmus University Medical Center, Rotterdam, Netherlands, Rotterdam, Netherlands

,

C M den Hoed

⁶Erasmus University Medical Center, Department of Gastroenterology and Hepatology, Rotterdam, Netherlands

,

M Spaander

⁷Erasmus University Medical Center, Department of Gastroenterology ' Hepatology, Rotterdam, Netherlands

References
1 Pimentel-Nunes P, Libânio D, Marcos-Pinto R, Areia M, Leja M, Esposito G, Garrido M, Kikuste I, Megraud F, Matysiak-Budnik T, Annibale B, Dumonceau JM, Barros R, Fléjou JF, Carneiro F, van Hooft JE, Kuipers EJ, Dinis-Ribeiro M.. Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019. Endoscopy 2019; 51 (04): 365-388 Epub 2019 Mar 6. PMID: 30841008.